Who owns Pluristem Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Pluristem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pluristem Therapeutics stock

Who bought or sold Pluristem Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
ARK Investment Management 3.6M $17M -9% Mar 2021
Jane Street 942k $4.5M 571% Mar 2021
Susquehanna International 772k $3.7M 33% Mar 2021
Nia Impact Advisors 360k $1.7M 25% Mar 2021
Renaissance Technologies 331k $1.6M 100% Mar 2021
Citadel Advisors 257k $1.2M 124% Mar 2021
CCM Partners 220k $1.0M 100% Mar 2021
Two Sigma Investments 214k $1.0M 1187% Mar 2021
Two Sigma Advisers 199k $947k 841% Mar 2021
Meitav Dash Investments 168k $799k 100% Mar 2021
Sumitomo Mitsui Trust Holdings 121k $576k 6% Mar 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Pluristem Therapeutics?

Nikko Asset Management Americas 121k $576k 6% Mar 2021
Jpmorgan Chase & Co 75k $360k 1038% Mar 2021
Etf Managers 75k $340k 22% Mar 2021
Group One Trading 57k $271k 100% Mar 2021
Sabby Management 51k $242k 100% Mar 2021
Millennium Management 50k $352k 47% Dec 2020
CalPERS 48k $227k 0% Mar 2021
Focused Wealth Management 41k $196k 0% Mar 2021
State Street Corporation 39k $185k 7% Mar 2021
Bridgeway Capital Management 33k $157k 100% Mar 2021
Wolverine Trading 30k $135k 4% Mar 2021
Zurcher Kantonalbank 30k $142k 100% Mar 2021
Algert Coldiron Investors 27k $130k 100% Mar 2021
Walleye Trading 26k $125k 100% Mar 2021
Jump Financial 22k $103k 100% Mar 2021
UBS Group 20k $96k 22% Mar 2021
Cutler 19k $79k 213% Mar 2021
Hrt Financial 15k $72k -12% Mar 2021
SG3 Management 14k $68k 0% Mar 2021
Archford Capital Strategies 13k $57k 100% Mar 2021
Geode Capital Management 13k $60k 0% Mar 2021
HighTower Advisors 12k $58k 100% Mar 2021
Squarepoint Ops 12k $87k -10% Dec 2020
HAP Trading 11k $3.0k -13% Mar 2021
Raymond James & Associates 10k $49k -37% Mar 2021
Van Eck Associates Corp. 7.8k $37k 2% Mar 2021
Simplex Trading 7.4k $34.902200 100% Mar 2021
Wells Fargo & Company 6.0k $29k -39% Mar 2021
Sowell Financial Services 3.8k $15k 294% Mar 2021
Tower Research Capital 3.6k $33k 100% Mar 2021
Advisor Group Holdings 3.5k $18k -10% Mar 2021
Banque Cantonale Vaudoise 3.2k $15k 0% Mar 2021
Proequities 1.8k $8.0k 0% Mar 2021
Firestone Capital Management 1.6k $7.0k 0% Mar 2021
Endurance Wealth Management 1.5k $7.0k -25% Mar 2021
Bank of America Corporation 1.3k $6.6k -14% Mar 2021
IFP Advisors 1.3k $6.0k 100% Mar 2021
Royal Bank of Canada 1.0k $5.0k -20% Mar 2021
International Assets Investment Management 800.00 $6.0k 100% Mar 2021
Baldwin Brothers 740.00 $4.0k 0% Mar 2021
Steward Partners Investment Advisory 504.00 $2.4k 100% Mar 2021
NEXT Financial 500.00 $2.0k 0% Mar 2021
Certified Advisory Corp 500.00 $2.0k 100% Mar 2021
BDO Wealth Advisors 400.00 $2.0k 100% Mar 2021
Winch Advisory Services 209.00 $1.0k 0% Mar 2021
Riggs Asset Managment 155.00 $999.998000 0% Mar 2021
TFC Financial Management 149.00 $999.998600 -94% Mar 2021
Holloway Wealth Management 125.00 $1.0k 0% Mar 2021
Bank Of Montreal 120.00 $999.996000 -81% Mar 2021
Wealthcare Advisory Partners 100.00 $0 100% Mar 2021
Citigroup 79.00 $0 -24% Mar 2021
Harbour Investments 34.00 $0 100% Mar 2021

Who sold out of Pluristem Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna Fundamental Investments Dec 2020 41k $286k
Capstone Investment Advisors Dec 2020 18k $126k
Morgan Stanley Dec 2020 15k $105k
Chiron Capital Management Sep 2020 375.00 $4.0k
Covington Capital Management Dec 2020 200.00 $1.0k
Carroll Financial Associates Dec 2020 150.00 $1.0k